Scrutinizing Reverse-Payment Settlements
Settlements of Hatch-Waxman litigation between branded and generic pharmaceutical companies that include a "reverse payment" by the branded firm to the generic have been the subject of significant antitrust litigation over...To view the full article, register now.
Already a subscriber? Click here to view full article